ID 9939
File
Authors
Harada, Tomoya Division of Respiratory Medicine and Rheumatology, Faculty of Medicine, Tottori University Researchers DB
Kato, Ryohei Division of Respiratory Medicine and Rheumatology, Faculty of Medicine, Tottori University
Sueda, Yuriko Division of Respiratory Medicine and Rheumatology, Faculty of Medicine, Tottori University
Funaki, Yoshihiro Division of Respiratory Medicine and Rheumatology, Faculty of Medicine, Tottori University Researchers DB
Takata, Miki Division of Respiratory Medicine and Rheumatology, Faculty of Medicine, Tottori University Researchers DB
Okazaki, Ryota Division of Respiratory Medicine and Rheumatology, Faculty of Medicine, Tottori University Researchers DB
Hasegawa, Yasuyuki Division of Rheumatology, Tottori Prefectural Central Hospital
Yamasaki, Akira Division of Respiratory Medicine and Rheumatology, Faculty of Medicine, Tottori University Researchers DB KAKEN
Keywords
Dose reduction
efficacy
pneumocystis pneumonia
prophylaxis
sulfamethoxazole-trimethoprim
Publisher
Taylor & Francis
Content Type
Journal Article
ISSN
14397595
EISSN
14397609
Journal Title
MODERN RHEUMATOLOGY
Current Journal Title
MODERN RHEUMATOLOGY
Volume
31
Issue
3
Start Page
629
End Page
635
Published Date
2020-09-08
Publisher-DOI
Text Version
Author
Rights
© 2020 Japan College of Rheumatology. This is an Accepted Manuscript of an article published by Taylor & Francis in MODERN RHEUMATOLOGY on 09 Sep 2020, available online: https://www.tandfonline.com/doi/10.1080/14397595.2020.1812834
Citation
Harada Tomoya, Kato Ryohei, Sueda Yuriko, et al. The efficacy and safety of reduced-dose sulfamethoxazole-trimethoprim for chemoprophylaxis ofPneumocystispneumonia in patients with rheumatic diseases. MODERN RHEUMATOLOGY. 2020, 31(3), 629-635. doi:10.1080/14397595.2020.1812834
Department
Faculty of Medicine/Graduate School of Medical Sciences/University Hospital
Language
English
Web of Science Key ut
WOS:000567584200001